John P. Schmid - May 10, 2024 Form 4 Insider Report for Xeris Biopharma Holdings, Inc. (XERS)

Role
Director
Signature
/s/ Beth Hecht, as Attorney-in-Fact
Stock symbol
XERS
Transactions as of
May 10, 2024
Transactions value $
$10,314
Form type
4
Date filed
5/10/2024, 04:04 PM
Previous filing
Mar 25, 2024
Next filing
Jun 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XERS Common Stock Purchase $10.3K +5.4K +49.09% $1.91 16.4K May 10, 2024 By: The Schmid Family Trust dated August 15, 2017 F1
holding XERS Common Stock 63.2K May 10, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.